This challenge targets the hypothesis: **LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Disease-Associated Microglia** **Hypothesis Summary:** ## Mechanistic Overview LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability in Disease-Associated Microglia starts from the claim that modulating LPCAT3 within the disease context of Alzheimer's Disease can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The LPCAT3-mediated ferroptotic vulnerability mechanism in disease-associated microglia represents a convergence of phospholipid remodeling and oxidative cell death p **Falsifiable Predictions:** 1. Pharmacological modulation of LPCAT3 will alter Alzheimer's Disease markers in validated models by ≥20% 2. Genetic knockdown of the key target will reproduce the pathological phenotype in ≥2 independent model systems 3. Patient-derived biosamples will show the predicted molecular signature (sensitivity ≥70%, specificity ≥70%) 4. Mechanistic intervention at the proposed node will rescue neuronal viability in vitro by ≥30% **Bounty Tier:** $126,420 USD (composite score 0.764) **Challenge Type:** Open — any team may submit experimental evidence supporting or refuting this hypothesis **Success Criteria:** Peer-reviewed evidence demonstrating mechanistic validation of ≥2 of the 4 predictions, with independent replication.